BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18038871)

  • 41. Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational study.
    Lapeyre-Prost A; Perkins G; Vallee M; Pozet A; Tougeron D; Maillet M; Locher C; Dreanic J; Legoux JL; Lièvre A; Lecaille C; Sabate JM; Mary F; Bonnetain F; Jaulmes-Bouillot H; Behal F; Landi B; Taieb J
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101709. PubMed ID: 33930588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiation oncology quality: aggressiveness of cancer care near the end of life.
    Toole M; Lutz S; Johnstone PA
    J Am Coll Radiol; 2012 Mar; 9(3):199-202. PubMed ID: 22386167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality of end-of-life care of advanced cancer patients in mainland China-a retrospective cohort of 441 hospital-death in a public funded comprehensive hospital.
    Li JS; Lam TC; Jing HM; Chen X; Cao MY; Huang C; Yang L; Xu ZY; Jiang Y; Li SS; Chen F; Han Y; Zhang YS; Lam KO; Lee AWM
    Ann Palliat Med; 2020 Nov; 9(6):4514-4521. PubMed ID: 32692211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. End of life care for the most common women cancers in Taiwan.
    Pan HJ; Chang HT; Huang WC; Lin HC
    Public Health; 2020 Sep; 186():119-124. PubMed ID: 32818724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between aggressive care and bereaved families' evaluation of end-of-life care for veterans with non-small cell lung cancer who died in Veterans Affairs facilities.
    Ersek M; Miller SC; Wagner TH; Thorpe JM; Smith D; Levy CR; Gidwani R; Faricy-Anderson K; Lorenz KA; Kinosian B; Mor V
    Cancer; 2017 Aug; 123(16):3186-3194. PubMed ID: 28419414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urban and rural differences in geographical accessibility to inpatient palliative and end-of-life (PEoLC) facilities and place of death: a national population-based study in England, UK.
    Chukwusa E; Verne J; Polato G; Taylor R; J Higginson I; Gao W
    Int J Health Geogr; 2019 May; 18(1):8. PubMed ID: 31060555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Palliative Chemotherapy Near the End of Life in Oncology Patients.
    Zhang Z; Chen ML; Gu XL; Liu MH; Zhao WW; Cheng WW
    Am J Hosp Palliat Care; 2018 Sep; 35(9):1215-1220. PubMed ID: 29529885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early palliative intervention for patients with advanced cancer.
    Otsuka M; Koyama A; Matsuoka H; Niki M; Makimura C; Sakamoto R; Sakai K; Fukuoka M
    Jpn J Clin Oncol; 2013 Aug; 43(8):788-94. PubMed ID: 23737605
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intensity of Medical Interventions between Diagnosis and Death in Patients with Advanced Lung and Colorectal Cancer: A CanCORS Analysis.
    Brooks GA; Cronin AM; Uno H; Schrag D; Keating NL; Mack JW
    J Palliat Med; 2016 Jan; 19(1):42-50. PubMed ID: 26600474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary care continuity and location of death for those with cancer.
    Burge F; Lawson B; Johnston G; Cummings I
    J Palliat Med; 2003 Dec; 6(6):911-8. PubMed ID: 14733683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of palliative care services on the aggressiveness of end-of-life care in the Veteran's Affairs cancer population.
    Gonsalves WI; Tashi T; Krishnamurthy J; Davies T; Ortman S; Thota R; Aldoss I; Ganta A; Kalaiah M; Didwaniya N; Eberle C; Ganti AK; Silberstein PT; Subbiah S
    J Palliat Med; 2011 Nov; 14(11):1231-5. PubMed ID: 21877925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemotherapy at the End of Life.
    Urvay S; Civelek B; Özaslan E; Sürel AA
    J Palliat Care; 2021 Apr; 36(2):73-77. PubMed ID: 32762320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aggressiveness of end-of-life care for patients with colorectal cancer in Alberta, Canada: 2006-2009.
    Hu W; Yasui Y; White J; Winget M
    J Pain Symptom Manage; 2014 Feb; 47(2):231-44. PubMed ID: 23870414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The EOLO (End-of-Life Ovarian Cancer) Study: Approach to Ovarian Cancer Patients at the End of Life.
    Palaia I; Tomao F; Santangelo G; Di Pinto A; Sassu CM; Perniola G; Musella A; Di Donato V; Giancotti A; Benedetti Panici P
    Oncology; 2019; 97(5):306-310. PubMed ID: 31437848
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Deficits in management of patients with colorectal carcinoma in Germany. Results of multicenter documentation of therapy algorithms].
    Grothey A; Kellermann L; Schmoll HJ
    Med Klin (Munich); 2002 May; 97(5):270-7. PubMed ID: 12078387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patterns of End-of-Life Oncologic Care for Stage IV Non-small Cell Lung Cancer in the United States.
    Haque W; Verma V; Butler EB; Teh BS
    Anticancer Res; 2019 Jun; 39(6):3137-3140. PubMed ID: 31177159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Palliative care needs of advanced cancer patients in the emergency department at the end of life: an observational cohort study.
    Verhoef MJ; de Nijs E; Horeweg N; Fogteloo J; Heringhaus C; Jochems A; Fiocco M; van der Linden Y
    Support Care Cancer; 2020 Mar; 28(3):1097-1107. PubMed ID: 31197539
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is In-Hospital Mortality Higher in Patients With Metastatic Lung Cancer Who Received Treatment in the Last Month of Life? A Retrospective Cohort Study.
    Mieras A; Pasman HRW; Onwuteaka-Philipsen BD; Dingemans AMC; Kok EV; Cornelissen R; Jacobs W; van den Berg JW; Welling A; Bogaarts BAHA; Pronk L; Becker-Commissaris A
    J Pain Symptom Manage; 2019 Nov; 58(5):805-811. PubMed ID: 31283970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of Palliative Chemotherapy for Advanced Bladder Cancer: Patterns of Care in Routine Clinical Practice.
    Robinson AG; Wei X; Mackillop WJ; Peng Y; Booth CM
    J Natl Compr Canc Netw; 2016 Mar; 14(3):291-8. PubMed ID: 26957615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and determinants of end-of-life chemotherapy use in patients with metastatic breast cancer.
    Mathew A; Achkar T; Abberbock S; Sandhu GS; Jacob ME; Villgran VD; Rosenzweig MQ; Puhalla S; Brufsky AM
    Breast J; 2017 Nov; 23(6):718-722. PubMed ID: 28845536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.